This exploration compound was initial documented by Hoffman-La Roche in 2009. It’s among numerous benzodiazepines within the imidazobenzodiazepine subgroup assumed to provide nootropic Rewards. It’s unclear why this drug wasn’t investigated further, but there are studies this compound has become detected on designer and street-degree drug markets [112]. Most of https://meistero577esd2.theisblog.com/profile